Oscar Health, Inc. (OSCR) Earnings Call Transcripts

38 earnings calls from May 2021 to August 6, 2026

NYSE US Financials Insurance

Oscar Health, Inc.'s Latest Earnings Call - June 8, 2026

In the Q2 2026 earnings call for Oscar Health, Inc. (OSCR:US), management reported a strong start to the year, reaffirming full-year guidance amid favorable membership trends and utilization metrics. The company ended open enrollment with 3.4 million members, stabilizing at approximately 3 million in Q2. Notably, the final 2025 Wakely report revealed a $130 million positive variance, providing a significant tailwind for 2026. Management indicated that while they are optimistic about market morbidity coming in lighter than expected, they are holding off on guidance updates pending the first 2026 Wakely report due at the end of June.

Reported metrics

MetricValueContext
Membership 3.0M (inline) vs 3.4M at end of open enrollment, stable at expected levels
Final 2025 Wakely Report Variance $130M (positive) favorable to prior accruals, indicating positive trend
Market Morbidity Expectations Lighter than expected (positive) suggesting potential upside for 2026
Utilization Trends Modestly favorable (positive) consistent improvements month over month
Guidance Update Maintained (neutral) no changes until first 2026 Wakely report is received
Market Contraction Estimate 20% to 30% (neutral) pricing based on a 30% contraction assumption

Guidance from management

Oscar Health reaffirmed its full-year guidance but is awaiting the first 2026 Wakely report before making any updates. Management remains optimistic about favorable market conditions and utilization trends.

What management said

I think that it would -- I think that there's some important things that would cause us to need to adjust some of the key inputs that go into pricing. So we'll be carefully monitored in that.
— Richard Blackley, June 8, 2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the impact of regulatory changes on pricing strategies for 2027 and the overall stability of the market amid ongoing litigation. There is also apprehension about the accuracy of enrollment data in the market, as highlighted by the Paragon report.

Main topics on the call

Read the full Oscar Health, Inc. transcript (June 8, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Oscar Health, Inc.

Oscar Health, Inc. (OSCR) is a publicly listed company in the Insurance industry, within the Financials sector. It trades on NYSE and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 38 calls on record spanning May 13, 2021 to August 6, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 38 Oscar Health, Inc. earnings call transcripts on record, spanning May 13, 2021 to August 6, 2026. Based on this history, Oscar Health, Inc. reports quarterly. The most recent call on file is dated August 6, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
OSCR
Exchange
NYSE
Country
US
Sector
Financials
Industry
Insurance
Calls on record
38
First call
May 13, 2021
Most recent
August 6, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Aug 6, 2026 Read transcript
Company Conference Presentations Jun 8, 2026 Read transcript
Q1 FY2026 May 6, 2026 Read transcript
Q4 FY2025 Feb 10, 2026 Read transcript
Company Conference Presentations Nov 10, 2025 Read transcript
Q3 FY2025 Nov 6, 2025 Read transcript
Q2 FY2025 Aug 6, 2025 Read transcript
Q1 FY2025 May 7, 2025 Read transcript
Q4 FY2024 Feb 4, 2025 Read transcript
Q3 FY2024 Nov 7, 2024 Read transcript
Company Conference Presentations Sep 5, 2024 Read transcript
Q2 FY2024 Aug 7, 2024 Read transcript
Analyst/Investor Day Jun 7, 2024 Read transcript
Company Conference Presentations May 15, 2024 Read transcript
Q1 FY2024 May 7, 2024 Read transcript
Q4 FY2023 Feb 7, 2024 Read transcript
Company Conference Presentations Jan 10, 2024 Read transcript
Q3 FY2023 Nov 7, 2023 Read transcript
Company Conference Presentations Sep 11, 2023 Read transcript
Q2 FY2023 Aug 8, 2023 Read transcript
Company Conference Presentations May 10, 2023 Read transcript
Q1 FY2023 May 9, 2023 Read transcript
Special Calls Mar 28, 2023 Read transcript
Q4 FY2022 Feb 9, 2023 Read transcript
Company Conference Presentations Jan 12, 2023 Read transcript
Q3 FY2022 Nov 8, 2022 Read transcript
Company Conference Presentations Sep 12, 2022 Read transcript
Q2 FY2022 Aug 11, 2022 Read transcript
Company Conference Presentations May 12, 2022 Read transcript
Q1 FY2022 May 10, 2022 Read transcript
Analyst/Investor Day Mar 25, 2022 Read transcript
Q4 FY2021 Feb 10, 2022 Read transcript
Shareholder/Analyst Calls Jan 27, 2022 Read transcript
Q3 FY2021 Nov 10, 2021 Read transcript
Company Conference Presentations Sep 14, 2021 Read transcript
Q2 FY2021 Aug 12, 2021 Read transcript
Company Conference Presentations Jun 8, 2021 Read transcript
Q1 FY2021 May 13, 2021 Read transcript